Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the leading clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Leveraging 60,000 sq. ft. purpose-built cell therapy development and industrial-grade cGMP cleanroom space with Resilience’s cloud-based, digit...igital-first electronic systems, CTMC works hand in hand with MD Anderson’s clinic to coordinate all logistics of cell therapy manufacturing, infusion, patient care and clinical correlate analysis. This integrated approach gives novel, first-in-human therapies the best chance to declare their potential and demonstrate proof of principle in a patient-efficient manner.